Total gastrectomy risk model: Data from 20,011 Japanese patients in a nationwide internet-based database

Annals of Surgery

Volumn 260, Issue 6, 2014, Pages 1034-1039

  Watanabe, Masayuki ^a   Miyata, Hiroaki ^a,b   Gotoh, Mitsukazu ^a,b   Baba, Hideo ^a   Kimura, Wataru ^a   Tomita, Naohiro ^a   Nakagoe, Tohru ^a   Shimada, Mitsuo ^a   Kitagawa, Yuko ^a   Sugihara, Kenichi ^a   Mori, Masaki ^a  

^a National Clinical Database Data Quality Management Subcommittee   (Japan)

^b National Clinical Database   (Japan)

Author keywords

30 day mortality; National Clinical Database; Risk factors of mortality; Risk model; Total gastrectomy

Indexed keywords

ALKALINE PHOSPHATASE;

AGED; ARTICLE; DIALYSIS; DISSEMINATED CANCER; FEMALE; HUMAN; INTERNET; JAPANESE (PEOPLE); MAJOR CLINICAL STUDY; MALE; MORBIDITY; PREOPERATIVE PERIOD; PRIORITY JOURNAL; SURGICAL MORTALITY; SURGICAL RISK; THROMBOCYTE COUNT; TOTAL STOMACH RESECTION; CLINICAL TRIAL; CONFIDENCE INTERVAL; EPIDEMIOLOGY; FACTUAL DATABASE; FOLLOW UP; GASTRECTOMY; HEALTH SURVEY; JAPAN; MORTALITY; MULTICENTER STUDY; POSTOPERATIVE COMPLICATIONS; PROCEDURES; RETROSPECTIVE STUDY; RISK; RISK ASSESSMENT; RISK FACTOR; SURVIVAL RATE; TRENDS;

AGED; CONFIDENCE INTERVALS; DATABASES, FACTUAL; FEMALE; FOLLOW-UP STUDIES; GASTRECTOMY; HOSPITAL MORTALITY; HUMANS; INTERNET; JAPAN; MALE; MORBIDITY; ODDS RATIO; POPULATION SURVEILLANCE; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SURVIVAL RATE;

EID: 84922334605     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0000000000000781     Document Type: Article

References (31)

1. Siegel R, Naishadham D, Jemal A. Cancer statics, 2012. CA Cancer J Clin. 2012;62: 10-29.
2. Bray F, Ren JS, Masuyer E, et al. Global estimates of cancer prevalence for 27 sites in the adult population in 2008. Int J Cancer 2013;132: 1133-1145.
3. Ott K, Lordick F, Blank S, et al. Gastric Cancer: Surgery in 2011. Langenbecks Arch Surg. 2011;396: 743-758.
4. Nitenberg G, Raynard B. Nutritional support of the cancer patient: Issues and dilemmas. Crit Rev Oncol Hematol. 2000;34: 137-168.
5. Kim KM, An JY, Kim HI, et al. Major early complications following open, laparoscopic and robotic gastrectomy. Br J Surg. 2012;99: 1681-1687.
6. Benhamiche AM, Faivre J, Tazi AM, et al. Time trends in diagnostic strategy, treatment, and prognosis of gastric cancer in the elderly: A population based study. Eur J Cancer Prev. 1997;6: 71-77.
7. Shiloach M, Frencher SK, Jr, Steeger JE, et al. Toward robust information: Data quality and inter-rater reliability in the American College of Surgeons National Surgical Quality Improvement Program. J Am Coll Surg. 2010;210: 6-16.
8. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: A new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240: 205-213.
9. Roder DM. The epidemiology of gastric cancer. Gastric Cancer. 2002;5: 5-11.
10. National Cancer Center, Center for Cancer Control and Information Services. Monitoring of cancer incidence in Japan. 2007. Available at http://ganjoho.jp/data/professional/statistics/odjrh3000000hwsa-Att/mcij2007 report.pdf. Accessed November 20, 2012.
11. Feldman RA. Epidemiologic observations and open questions about disease and infection caused by Helicobacter pylori. In: AchtmanM, Suerbaum S, eds. Helicobacter pylori: Molecular and Cellular Biology.Wymondham, England: Horizon Scientific Press; 2001: 29-51.
12. Robertson CS, Chung SC, Woods SD, et al. A prospective randomized trial comparing R1 subtotal gastrectomywith R3 total gastrectomy for antral cancer. Ann Surg. 1994;220: 176-182.
13. Bozzetti F, Marubini E, Bonfanti G, et al. Total versus subtotal gastrectomy: Surgical morbidity and mortality rates in a multicenter Italian randomized trial. The ItalianGastrointestinal Tumor Study Group. Ann Surg. 1997;226: 613-620.
14. Davies J, JohnstonD, Sue-LingH, et al. Total or subtotal gastrectomy for gastric carcinoma? A study of quality of life. World J Surg. 1998;22: 1048-1055.
15. Hartgrink HH, van deVelde CJ, PutterH, et al. Extended lymph node dissection for gastric cancer: Who may benefit? Final results of the randomized Dutch Gastric Cancer Group trial. J Clin Oncol. 2004;22: 2069-2077.
16. Bonnenkamp JJ, Hermans J, SasakoM, et al. Dutch Gastric Cancer Group. Extended lymph-node dissection for gastric cancer. N Engl JMed. 1999;340: 908-914.
17. Cuschieri A, Fayers P, Fielding J, et al. Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: Preliminary results of the MRC randomised controlled surgical trial. The Surgical Cooperative Group. Lancet. 1996;347: 995-999.
18. Nashimoto A, Akazawa K, Isobe Y, et al. Gastric cancer treated in 2002 in Japan: 2009 annual report of the JGCA nationwide registry. Gastric Cancer. 2013;16: 1-27.
19. Viste A. Predicted morbidity and mortality in major gastroenterological surgery. Gastric Cancer. 2012;15: 1-2.
20. Sutton R, Bann S, Brooks M, et al. The Surgical Risk Scale as an improved tool for risk analysis in comparative surgical audit. Br J Surg. 2002;89: 763-768.
21. Vacanti CJ, van Houton RJ, Hill RC. A statistical analysis of the relationship of physical status to postoperative mortality in 68, 388 cases. Anesth Analg. 1970;49: 564-566.
22. Klotz HP, Candinas D, Platz H, et al. Preoperative risk assessment in elective general surgery. Br J Surg. 1996;83: 1788-1791.
23. Hall JC, Hall JL. ASA status and age predict adverse events after abdominal surgery. J Qual Clin Pract. 1996;16: 103-108.
24. Mahar AL, Coburn NG, Singh S, et al. A systematic review of surgery for non-curative gastric cancer. Gastric Cancer. 2012;15: S125-S137.
25. Tsujinaka T, Sasako M, Yamamoto S, et al. Influence of overweight on surgical complications for gastric cancer: Results from a randomized control trial comparing D2 and extended para-Aortic D3 lymphadenectomy (JCOG9501). Ann Surg Oncol. 2007;14: 355-361.
26. Kulig J, Sierzega M, Kolodziejczyk P, et al. Implications of overweight in gastric cancer: A multicenter study in aWestern patient population. Eur J Surg Oncol. 2010;36: 969-976.
27. Cunningham D, Allum WH, Stenning SP, et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med. 2006;355: 11-20.
28. Sakuramoto S, SasakoM, Yamaguchi T, et al. Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med. 2007;357: 1810-1820.
29. Dutta S, Al-Mrabt NM, Fullarton GM, et al. A comparison of POSSUM and GPS models in the prediction of post-operative outcome in patients undergoing oesophago-gastric cancer. Ann Surg Oncol. 2011;18: 2808-2817.
30. Haga Y, Ikei S, Ogawa M. Estimation of Physiologic Ability and Surgical Stress (E-PASS) as a new prediction scoring system for postoperative morbidity and mortality following elective gastrointestinal surgery. Surg Today. 1999;29: 219-225.
31. Haga Y, Wada Y, Takeuchi H, et al. Evaluation of modified Estimation of Physiologic Ability and Surgical Stress in gastric carcinoma surgery. Gastric Cancer. 2012;15: 7-14.